and mystical experience survey, 282 –84
with psilocybin, 254 –72, 284
recaps and reflections on, 250 –54, 269 –72, 281 –84
and search for a guide, 231 –35
as “spiritual” experience, 288 –90
with The Toad (5-MeO-DMT), 272 –90
Psychedelic Psychiatry (Dyck), 146n
Psychedelic Science 2017, 397
psychedelic therapy
as “applied mysticism,” 207
and aspirations of proponents, 173
and betterment of well people, 45 , 51 , 78 , 401 , 404
and California Institute of Integral Studies, 233
and Cohen’s ambivalence about LSD, 158 –59
criticisms and challenges faced by, 207 –8
and ego dissolution, 389 –90
emergence of paradigm, 160 , 163 –64, 169 –71, 207
and established psychiatric field, 207
at frontier of spirituality and science, 334
future of, 400 –405
growing recognition of, 399
and Hubbard, 160 , 164 , 169 –70, 171 , 207
key role of experience in, 149 , 169
and low risks, 210
and previous theoretical models, 207
and priming patients, 169 –70
protocols and agreements of, 215 , 226 –27
and “psychedelic-assisted therapy” term, 365 , 399
range of disorders addressed by, 382 –83
as reboot of system, 366 , 384 , 389
results of, 368 –69
and return of symptoms, 380 –81
revival of, 369
role of environment in, 163 –64, 169 –70, 207 –8, 365
role of therapist in, 365 –66, 368 (see also guides)
shamanism’s role in, 334
spiritual trappings of, 207
and suggestibility of psychedelics, 158 –59, 170
visual imagery in, 365 –66
See also addiction; cancer patient research; depression
“psychedelics” term, 18 –19, 144 –45, 160 , 162 –63
psychiatry field, 207 –8, 211 , 400
psychoanalysis, 149 , 155 , 207 , 296 –97, 311
psycholytic model, 154 –57, 207
psychosis
and entropic brain theory, 313 , 385
panic reactions mistaken for, 210
psychotic breaks, 3 , 14 , 209 , 211
and psychotomimetic model, 145 , 150 –51, 154 , 162
and risks associated with psychedelics, 14 , 233
frankie
(Frankie)
#1